Skip to main content
SpringerLink
Log in

Expression of Rb2/p130 protein correlates with the degree of malignancy in gliomas

  • Original Article
  • Published:
Brain Tumor Pathology Aims and scope Submit manuscript

Abstract

It has been reported that there is an inverse correlation between the immunohistochemical expression of Rb2/p130, a member of the retinoblastoma gene family, and the degree of malignancy in at least some histological types. In order to investigate the expression of this protein in gliomas, we evaluated 58 samples from patients with resected gliomas. We focused on the relationship between the degree of malignancy of the glioma and the immunohistochemical detection of Rb2/p130. Expression of Rb2/p130 was observed in 38 glioma specimens (65.5%), including a high expression level in low-grade glioma specimens (>30% positive cells in 84% of tumors) and a low expression level in high-grade glioma specimens (>30% positive cells in 12% of tumors). The most aggressive of the gliomas exhibited very low to undetectable levels of Rb2/p130. Moreover, we observed an inverse correlation between Rb2/p130 expression and the degree of malignancy. These findings suggest that the differentiation of gliomas might be partially mediated by the Rb2/p130 gene, and that Rb2/p130 expression can additionally be an indicator of a better prognosis in patients with gliomas.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Roth W, Weller M (1999) Chemotherapy and immunotherapy of malignant glioma: molecular mechanisms and clinical perspectives. Cell Mol Life Sci 56:481–506

    Article  PubMed  CAS  Google Scholar 

  2. Chakravarti A, Delaney MA, Noll F, et al (2001) Prognostic and pathologic significance of quantitative protein expression profiling in human gliomas. Clin Cancer Res 7:2387–2395

    PubMed  CAS  Google Scholar 

  3. Ueki K, Nishikawa R, Nakazato Y, et al (2002) Correlation of histology and molecular genetic analysis of 1p, 19p, 10q, TP53, EGFR, CDK4, and CDKN2A in 91 astrocytic and oligodendroglial tumors. Clin Cancer Res 8:196–201

    PubMed  CAS  Google Scholar 

  4. Pignatti F, van den Bent M, Curran D, et al (2002) Prognostic factors for survival in adult patients with cerebral low-grade glioma. J Clin Oncol 20:2076–2084

    Article  PubMed  Google Scholar 

  5. Tortosa A, Vinolas N, Villa S, et al (2003) Prognostic implication of clinical, radiologic, and pathologic features in patients with anaplastic gliomas. Cancer 97:1063–1071

    Article  PubMed  Google Scholar 

  6. Simmons ML, Lamborn KR, Takahashi M, et al (2001) Analysis of complex relationships between age, p53, epidermal growth factor receptor, and survival in glioblastoma patients. Cancer Res 61:1122–1128

    PubMed  CAS  Google Scholar 

  7. Nozaki M, Tada M, Kobayashi H, et al (1999) Roles of the functional loss of p53 and other genes in astrocytoma tumorigenesis and progression. Neuro-oncology 1:124–137

    PubMed  CAS  Google Scholar 

  8. Hara A, Saegusa M, Mikami T, et al (2001) Loss of DCC expression in astrocytomas: relation to p53 abnormalities, cell kinetics, and survival, J Clin Pathol 54:860–865

    PubMed  CAS  Google Scholar 

  9. Birner P, Piribauer M, Fischer I, et al (2002) Prognostic relevance of p53 protein expression in glioblastoma. Oncol Rop 9:703–707

    CAS  Google Scholar 

  10. Korshunov A, Golanov A (2001) The prognostic significance of DNA topoisomerase II-alpha (Ki-S1), p21/Cip-1, and p27/Kip-1 protein immunoexpression in oligodendrogliomas. Arch Pathol Lab Med 125:892–898

    PubMed  CAS  Google Scholar 

  11. Glaser T, Wagenknecht B, Weller M (2001) Identification of p21 as a target of cycloheximide-mediated facilitation of CD95-mediated apoptosis in human malignant glioma cells. Oncogene 20:4757–4767

    Article  PubMed  CAS  Google Scholar 

  12. Kamitani H, Taniura S, Watanabe K, et al (2002) Histone acetylation may suppress human glioma cell proliferation when p21 WAF/Cip1 and gelsolin are induced. Neuro-oncology 4:95–101

    Article  PubMed  CAS  Google Scholar 

  13. Tamiya T, Mizumatsu S, Ono Y, et al (2001) High cyclin E/low p27Kip1 expression is associated with poor prognosis in astrocytomas. Acta Neuropathol (Berl) 101:334–340

    CAS  Google Scholar 

  14. Kirla RM, Haapasalo HK, Kalimo H, et al (2003) Low expression of p27 indicates a poor prognosis in patients with high-grade astrocytomas. Cancer 97:644–648

    Article  PubMed  Google Scholar 

  15. Zagzag D, Blanco C, Friendlander DR, et al (2003) Expression of p27KIP1 in human gliomas: relationship between tumor grade, proliferation index, and patient survival. Hum Pathol 34:48–53

    Article  PubMed  CAS  Google Scholar 

  16. Komata T, Kanzawa T, Takeuchi H, et al (2003) Antitumour effect of cyclin-dependent kinase inhibitors (p16(INK4A), p18(INK4C), p19(INK4D), p21(WAF1/CIP1) and p27(KIP1)) on malignant glioma cells. Br J Cancer 88:1277–1280

    Article  PubMed  CAS  Google Scholar 

  17. Whyte P (1995) The retinoblastoma protein and its relatives. Semin Cancer Biol 6:83–90

    Article  PubMed  CAS  Google Scholar 

  18. Baldi A, De Luca A, Claudio PP, et al (1995) The RB2/p130 gene product is a nuclear protein whose phosphorylation is cell cycle regulated. J Cell Biochem 59:402–408

    Article  PubMed  CAS  Google Scholar 

  19. Claudio PP, De Luca A, Howard CM, et al (1996) Functional analysis of pRb2/p130 interaction with cyclins. Cancer Res 56:2003–2008

    PubMed  CAS  Google Scholar 

  20. Claudio PP, Howard CM, Baldi A, et al (1994) p130/pRb2 has growth suppressive properties similar to yet distinctive from those of retinoblastoma family members pRb and p107. Cancer Res 54:5556–5560

    PubMed  CAS  Google Scholar 

  21. Paggi MG, Baldi A, Giordano A, et al (1996) Retinoblastoma protein family in cell cycle and cancer: a review. J Cell Biochem 62:418–430

    Article  PubMed  CAS  Google Scholar 

  22. Baldi A, Esposito V, De Luca A, et al (1997) Differential expression of pRb2/p130 and p107 in normal human tissues and in primary lung cancer. Clin Cancer Res 3:1691–1697

    PubMed  CAS  Google Scholar 

  23. Caputi M, Groeger AM, Esposito V, et al (2002) Loss of pRb2/p130 expression is associated with unfavorable clinical outcome in lung cancer. Clin Cancer Res 8:3850–3856

    PubMed  CAS  Google Scholar 

  24. Nozoe T, Korenaga D, Itoh S, et al (2002) Clinicopathological significance of pRb2/p130 expression in squamous cell carcinoma of the esophagus. J Cancer Res Clin Oncol 128:691–696

    Article  PubMed  CAS  Google Scholar 

  25. Tanaka N, Ogi K, Kohama G (2001) pRb2/p130 protein expression is correlated with clinicopathologic findings in patients with oral squamous cell carcinoma. Cancer 92:2117–2125

    Article  PubMed  CAS  Google Scholar 

  26. Zamparelli A, Masciullo V, Bovicelli A, et al (2001) Expression of cell-cycle-associated proteins pRB2/p130 and p27kip in vulvar squamous cell carcinomas. Hum Pathol 32:4–9

    Article  PubMed  CAS  Google Scholar 

  27. Susini T, Baldi F, Howard CM, et al (1998) Expression of the retinoblastoma-related pRb2/p130 correlates with clinical outcome in endometrial cancer. J Clin Oncol 16:1085–1093

    PubMed  CAS  Google Scholar 

  28. Massaro-Giordano M, Baldi G, De Luca A, et al (1999) Differential expression of the retinoblastoma gene family members in choroidal melanoma: prognostic significance. Clin Cancer Res 5: 1455–1458

    PubMed  CAS  Google Scholar 

  29. Kleihues P, Burger PC (1993) In: World Health Organization international histological classification of tumors. Springer, Berlin Heidelberg New York, pp 13–16

    Google Scholar 

  30. Sabattini E, Bisgaard K, Ascani S, et al (1998) The EnVision++ system: a new immunohistochemical method for diagnostics and research. Critical comparison with the APAAP, ChemMate, CSA, LABC, and SABC techniques. J Clin Pathol 51:506–511

    Article  PubMed  CAS  Google Scholar 

  31. Kammerer U, Kapp M, Gassel AM, et al (2001) A new rapid immunohistochemical staining technique using the EnVision antibody complex. J Histochem Cytochem 49:623–630

    PubMed  CAS  Google Scholar 

  32. Kleihues P, Careuse WK (2002) World Health Organization classification of tumors: pathology and genetics of tumors of the nervous system. IARC, Lyon

    Google Scholar 

  33. Manni I, Tunici P, Cirenei N, et al (2002) Mxi1 inhibits the proliferation of U87 glioma cells through down-regulation of cyclin B1 gene expression. Br J Cancer 86:477–484

    Article  PubMed  CAS  Google Scholar 

  34. Bacon CL, Gallagher HC, Haughey JC, et al (2002) Antiproliferative action of valproate is associated with aberrant expression and nuclear translocation of cyclin D3 during the C6 glioma G1 phase. J Neurochem 83:12–19

    Article  PubMed  CAS  Google Scholar 

  35. Grana X, Garriga J, Mayol X (1998) Role of the retinoblastoma protein family, pRb, p107 and p130 in the negative control of cell growth. Oncogene 17:3365–3383

    Article  PubMed  Google Scholar 

  36. Garriga J, Limon A, Mayol X, et al (1998) Differential regulation of the retinoblastoma family of proteins during cell proliferation and differentiation. Biochem J 333:645–654

    PubMed  CAS  Google Scholar 

  37. Pucci B, Claudio PP, Masciullo V, et al (2002) pRb2/p130 promotes radiation-induced cell death in the glioblastoma cell line HJC12 by p73 upregulation and Bcl-2 downregulation. Oncogene 21:5897–5905

    Article  PubMed  CAS  Google Scholar 

  38. Galderisi U, Melone MA, Jori FP, et al (2001) pRb2/p130 gene overexpression induces astrocyte differentiation. Mol Cell Neurosci 17:415–425

    Article  PubMed  CAS  Google Scholar 

  39. Paggi MG, Bonetto F, Severino A, et al (2001) The retinoblastoma-related Rb2/p130 gene is an effector downstream of AP-2 during neural differentiation. Oncogene 20:2570–2578

    Article  PubMed  CAS  Google Scholar 

  40. Li Y, Graham C, Lacy S, et al (1993) The adenovirus E1A-associated 130-kD protein is encoded by a member of the retinoblastoma gene family and physically interacts with cyclins A and E. Genes Dev 7:2366–2377

    PubMed  CAS  Google Scholar 

  41. Yeung RS, Bell DW, Testa JR, et al (1993) The retinoblastomarelated gene, RB2, maps to human chromosome 16q12 and rat chromosome 19. Oncogene 8:3465–3468

    PubMed  CAS  Google Scholar 

  42. Claudio PP, Howard CM, Fu Y, et al (2000) Mutations in the retinoblastoma-related gene RB2/p130 in primary nasopharyngeal carcinoma. Cancer Res 60:812

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurosurgery First Department of Pathology, Kansai Medical University, Moriguchi, Osaka, Japan

    Qiang Li

  2. First Department of Pathology, Kansai Medical University, Moriguchi, Osaka, Japan

    Susumu Ikehara

  3. Department of Neurosurgery, Kansai Medical University, 10-15 Fumizono, 570-8507, Moriguchi, Osaka, Japan

    Yasuo Sakurai, Takashi Ryu, Keiichi Azuma, Kunikazu Yoshimura, Yasuo Yamanouchi & Keiji Kawamoto

Authors
  1. Qiang Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yasuo Sakurai
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Takashi Ryu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Keiichi Azuma
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Kunikazu Yoshimura
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Yasuo Yamanouchi
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Susumu Ikehara
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Keiji Kawamoto
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Keiji Kawamoto.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Li, Q., Sakurai, Y., Ryu, T. et al. Expression of Rb2/p130 protein correlates with the degree of malignancy in gliomas. Brain Tumor Pathol 21, 121–125 (2004). https://doi.org/10.1007/BF02482187

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02482187

Key words

Search

Navigation